APA (7th ed.) Citation

Goldstein, N., McLean, C., Gaddah, A., Doua, J., Keshinro, B., Bus-Jacobs, L., . . . Douoguih, M. Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Goldstein, Neil, et al. Lot-to-lot Consistency, Immunogenicity, and Safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola Virus Vaccine Regimen: A Phase 3, Randomized, Double-blind, Placebo-controlled Trial. Taylor & Francis Group.

MLA (9th ed.) Citation

Goldstein, Neil, et al. Lot-to-lot Consistency, Immunogenicity, and Safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola Virus Vaccine Regimen: A Phase 3, Randomized, Double-blind, Placebo-controlled Trial. Taylor & Francis Group.